SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-21-001788
Filing Date
2021-01-26
Accepted
2021-01-26 12:03:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 519745
2 ex4-7.htm EX-4.7 493483
3 ex5-1.htm EX-5.1 42100
4 ex23-1.htm EX-23.1 3603
  Complete submission text file 0001493152-21-001788.txt   1059999
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252430 | Film No.: 21552483
SIC: 2834 Pharmaceutical Preparations